{
    "Trade/Device Name(s)": [
        "Precision Xtra Blood \u03b2-Ketone Test Strips",
        "Optium Blood \u03b2-Ketone Test Strips"
    ],
    "Submitter Information": "Abbott Diabetes Care Inc.",
    "510(k) Number": "K060768",
    "Predicate Device Reference 510(k) Number(s)": [
        "K983504",
        "K040814"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JIN"
    ],
    "Summary Letter Date": "April 21, 2006",
    "Summary Letter Received Date": "March 22, 2006",
    "Submission Date": "March 21, 2006",
    "Regulation Number(s)": [
        "21CFR862.1435"
    ],
    "Regulation Name(s)": [
        "Ketones (nonquantitative) test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "\u03b2-Hydroxybutyrate",
        "\u03b2-Ketone"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood",
        "Venous whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Precision Xtra Diabetes Monitoring System"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric biosensor"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "Test Strip"
    ],
    "Document Summary": "FDA 510(k) summary for Abbott Precision Xtra and Optium Blood \u03b2-Ketone Test Strips for quantitative measurement of \u03b2-Hydroxybutyrate in whole blood using amperometric biosensor technology",
    "Indications for Use Summary": "For quantitative measurement of blood \u03b2-Ketone (Beta-Hydroxybutyrate) in fresh capillary whole blood from the fingertip; for self-testing or healthcare professional use; healthcare professionals may also use venous whole blood samples within 30 minutes of collection; for persons with diabetes and other conditions",
    "fda_folder": "Clinical Chemistry"
}